Table 3. Univariate Cox regression analysis showed the influencing genes of the poor prognosis of LUAD patients.
Gene | HR | HR.95L | HR.95H | P value |
---|---|---|---|---|
IL5RA | 0.567969541 | 0.354788527 | 0.909244169 | 0.018460133 |
POU2AF1 | 0.845127424 | 0.729284998 | 0.979370705 | 0.02528008 |
TPSAB1 | 0.882145437 | 0.784237159 | 0.992277097 | 0.036696354 |
LILRB3 | 0.693103481 | 0.507451451 | 0.94667664 | 0.021197708 |
TNFRSF11A | 1.342513034 | 1.010304964 | 1.783957628 | 0.042291011 |
TNFSF12 | 0.734870574 | 0.587851237 | 0.918658882 | 0.006832572 |
SPN | 0.776883091 | 0.643736666 | 0.937568681 | 0.008487492 |
CCL23 | 0.808140618 | 0.658461621 | 0.991844076 | 0.04151735 |
TNFRSF13C | 0.79122038 | 0.642776791 | 0.973945697 | 0.02717529 |
IRF4 | 0.817449694 | 0.684234106 | 0.976601424 | 0.026362416 |
PLA2G1B | 0.879355908 | 0.791992086 | 0.976356743 | 0.016033967 |
CD79A | 0.886163139 | 0.803165593 | 0.977737487 | 0.016010351 |
PECAM1 | 0.771046003 | 0.630105179 | 0.943512222 | 0.011585317 |
MS4A2 | 0.700052865 | 0.540280972 | 0.907072503 | 0.006978937 |
CCL14 | 0.598738403 | 0.396642108 | 0.903806399 | 0.014632385 |
IL11 | 1.289066215 | 1.010263193 | 1.644810697 | 0.041143312 |
CD83 | 0.789017057 | 0.66590724 | 0.93488684 | 0.006183644 |
ITGAL | 0.800765117 | 0.677978583 | 0.945789128 | 0.008890182 |
CTSG | 0.72383541 | 0.569448846 | 0.920078607 | 0.008278353 |
CAMP | 0.72714556 | 0.55717819 | 0.948961526 | 0.018995652 |
CD19 | 0.786520514 | 0.657125374 | 0.941394964 | 0.008831838 |
TLR10 | 0.719753444 | 0.553719116 | 0.935573661 | 0.013984072 |
MS4A1 | 0.799304568 | 0.693873229 | 0.920755788 | 0.001909762 |
BTK | 0.733470106 | 0.600763588 | 0.895491015 | 0.002334972 |
F2RL1 | 1.209148957 | 1.051086802 | 1.390980459 | 0.007883053 |
C7 | 0.89802593 | 0.817405862 | 0.98659749 | 0.025018563 |
CFP | 0.683871416 | 0.492614918 | 0.949382765 | 0.023188729 |
C6 | 0.702597335 | 0.543092969 | 0.908947535 | 0.007218133 |
LUAD, lung adenocarcinoma.